Source: BioPharm

Auromedics: AuroMedics Pharma Issues Voluntary Recall Due to Glass and Silicone Particulates

On July 31, 2018, AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material. Each vial contains 7.05 mEq (162 mg) of sodium in a single-dose via

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Ronald F Quadrel's photo - CEO of Auromedics

CEO

Ronald F Quadrel

CEO Approval Rating

73/100

Read more